Literature DB >> 28386718

Globus pallidus MR signal abnormalities in children with chronic liver disease and/or porto-systemic shunting.

Sylviane Hanquinet1, Claire Morice2, Delphine S Courvoisier3, Vladimir Cousin2, Mehrak Anooshiravani4, Laura Merlini4, Valérie A McLin2.   

Abstract

OBJECTIVES: Detection of subclinical hepatic encephalopathy in children is difficult. We aimed to assess the changes in imaging of the central nervous system in children with chronic liver disease using MR imaging, diffusion, and 1H -spectroscopy.
METHODS: Forty three children with chronic liver disease and/or porto-systemic shunting (111.4±56.9 months) and 24 controls (72.0±51.8 months) underwent brain MRI/spectroscopy on a 1.5T to examine T1, T2, ADC, Cho/Cr, ml/Cr, Glx/Cr ratio spectroscopy in the globus pallidus. Patients were divided into 3 groups according to the ratios of globus pallidus/putamen T1 signal : isointense (i), hyperintense (h), much more hyperintense (h+). The relationship with clinical and biological data was analyzed.
RESULTS: T1 signal intensity and ml/Cr were significantly different between controls and group h+ (p=0.001). ADC did not differ significantly between groups. Age correlated strongly with the presence of a T1 signal ratio (p > 0.001). There was no correlation between imaging findings and biological parameters.
CONCLUSIONS: In children with chronic liver disease and/or porto-systemic shunting, the presence of a hyperintense T1 signal in the globus pallidus correlated strongly with age. Biological and clinical parameters were not predictive of these changes. MRI may become a useful screening tool for hepatic encephalopathy in children. KEY POINTS: • Children with chronic liver disease should undergo brain MRI during their follow-up • T1 hyperintensity of globus pallidus is suggestive of liver-related CNS involvement • MRS mI/Cr is decreased in children with chronic liver disease • Biological parameters (ammonium) were not predictive of hepatic encephalopathy • Duration of chronic liver disease may be causative the hepatic encephalopathy.

Entities:  

Keywords:  Child; Chronic liver disease; Hepatic encephalopathy; Portosystemic shunting; T1 hyperintense

Mesh:

Year:  2017        PMID: 28386718     DOI: 10.1007/s00330-017-4808-x

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  33 in total

Review 1.  MR imaging findings in hepatic encephalopathy.

Authors:  A Rovira; J Alonso; J Córdoba
Journal:  AJNR Am J Neuroradiol       Date:  2008-06-26       Impact factor: 3.825

2.  Value of the apparent diffusion coefficient for quantification of low-grade hepatic encephalopathy.

Authors:  Ryosuke Sugimoto; Motoh Iwasa; Masayuki Maeda; Naohito Urawa; Hideaki Tanaka; Naoki Fujita; Yoshinao Kobayashi; Kan Takeda; Masahiko Kaito; Yoshiyuki Takei
Journal:  Am J Gastroenterol       Date:  2008-05-28       Impact factor: 10.864

Review 3.  The role of magnetic resonance imaging and spectroscopy in hepatic encephalopathy.

Authors:  Mark J W McPhail; Simon D Taylor-Robinson
Journal:  Metab Brain Dis       Date:  2010-03-11       Impact factor: 3.584

4.  Clues for minimal hepatic encephalopathy in children with noncirrhotic portal hypertension.

Authors:  Lorenzo D'Antiga; Patrizia Dacchille; Clementina Boniver; Sara Poledri; Sami Schiff; Lucia Zancan; Piero Amodio
Journal:  J Pediatr Gastroenterol Nutr       Date:  2014-12       Impact factor: 2.839

5.  Increased manganese concentrations in pallidum of cirrhotic patients.

Authors:  G Pomier-Layrargues; L Spahr; R F Butterworth
Journal:  Lancet       Date:  1995-03-18       Impact factor: 79.321

6.  Manganese deposition in basal ganglia structures results from both portal-systemic shunting and liver dysfunction.

Authors:  C Rose; R F Butterworth; J Zayed; L Normandin; K Todd; A Michalak; L Spahr; P M Huet; G Pomier-Layrargues
Journal:  Gastroenterology       Date:  1999-09       Impact factor: 22.682

Review 7.  Cerebral changes in hepatic encephalopathy.

Authors:  A Watanabe
Journal:  J Gastroenterol Hepatol       Date:  1998-07       Impact factor: 4.029

8.  Quantitative multivoxel 1H MR spectroscopy of the brain in children with acute liver failure.

Authors:  Paul E Sijens; Heyder Alkefaji; Roelineke J Lunsing; Francjan J van Spronsen; Linda C Meiners; Matthijs Oudkerk; Henkjan J Verkade
Journal:  Eur Radiol       Date:  2008-05-21       Impact factor: 5.315

9.  Manganese and chronic hepatic encephalopathy.

Authors:  D Krieger; S Krieger; O Jansen; P Gass; L Theilmann; H Lichtnecker
Journal:  Lancet       Date:  1995-07-29       Impact factor: 79.321

Review 10.  The why and wherefore of hepatic encephalopathy.

Authors:  Vijay Pb Grover; Joshua M Tognarelli; Nicolas Massie; Mary Me Crossey; Nicola A Cook; Simon D Taylor-Robinson
Journal:  Int J Gen Med       Date:  2015-12-16
View more
  3 in total

Review 1.  Presentation of Congenital Portosystemic Shunts in Children.

Authors:  Atessa Bahadori; Beatrice Kuhlmann; Dominique Debray; Stephanie Franchi-Abella; Julie Wacker; Maurice Beghetti; Barbara E Wildhaber; Valérie Anne McLin
Journal:  Children (Basel)       Date:  2022-02-11

2.  Von Willebrand factor and esophageal varices in children with chronic liver diseases.

Authors:  Mohamed Abdel-Salam El-Guindi; Nermin Mohammed Adawy; Iman Shaban Osheba; Wafaa Masoud Khalifa; Hosam Eldin Mohammed Basiouny
Journal:  Clin Exp Hepatol       Date:  2021-12-23

3.  Longitudinal osmotic and neurometabolic changes in young rats with chronic cholestatic liver disease.

Authors:  Veronika Rackayova; Olivier Braissant; Anne-Laure Rougemont; Cristina Cudalbu; Valérie A McLin
Journal:  Sci Rep       Date:  2020-05-05       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.